Replies to post #21858 on The Rising Influence of Rising Affluence

[DewDiligence]

ABT 1Q20 sales by business segment:

  
 Medical devices* 38% (+3% YoY in const currency) 
 Nutrition        25% (+7% YoY in const currency) 
 Diagnostics      24% (+1% YoY in const currency) 
 Drugs†           14% (+9% YoY in const currency)

63% of overall sales were ex-US.

*Including diabetes care.
†Branded generics in emerging markets.

[DewDiligence]

ABT 2Q20 results:

https://abbott.mediaroom.com/2020-07-16-Abbott-Reports-Second-Quarter-2020-Results-Exceeds-Analysts-Expectations

The stock is flat in early trading.